NewEdge Advisors’s ImmunityBio IBRX Stock Holding History

NewEdge Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.69K	Hold	350	–	–	﹤0.01%	3744
2025 Q4	$693	Hold	350	–	–	﹤0.01%	4016
2025 Q3	$861	Hold	350	–	–	﹤0.01%	3897
2025 Q2	$924	Sell	350 -1	-0.3%	-$3	﹤0.01%	3726
2025 Q1	$1.06K	Hold	351	–	–	﹤0.01%	3616
2024 Q4	$899	Buy	351 +1	+0.3%	+$4	﹤0.01%	3579
2024 Q3	$1.3K	Hold	350	–	–	﹤0.01%	3463
2024 Q2	$2.21K	Buy	+350	New	+$2.31K	﹤0.01%	3311
2023 Q3	–	Sell	-250	Closed	-$695	–	3560
2023 Q2	$695	Hold	250	–	–	﹤0.01%	3293
2023 Q1	$455	Hold	250	–	–	﹤0.01%	3246
2022 Q4	$1	Buy	+250	New	+$1.37K	﹤0.01%	4017

Other funds holding IBRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return